APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Arginase 1 Monoclonal Antibody

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Arginase 1 Monoclonal Antibody Market Outlook and Growth Opportunities 2026

Report ID 173967170422 December 2025198 pages

Choose your research edition.

Industry ResearchArginase 1 Monoclonal Antibody Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Arginase 1 Monoclonal Antibody Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Arginase 1 Monoclonal Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Arginase 1 Monoclonal Antibody Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Arginase 1 Monoclonal Antibody Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Arginase 1 Monoclonal Antibody market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Arginase 1 Monoclonal Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Arginase 1 Monoclonal Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Arginase 1 Monoclonal Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Arginase 1 Monoclonal Antibody market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Arginase 1 Monoclonal Antibody market include Sino Biological, Inc., ZodelBiotec Ltd., MyBiosource, Inc., Innovative Research, Geno Technology, Inc., CUSABIO, Creative Diagnostics, CLOUD-CLONE CORP. and Biomatik, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Arginase 1 Monoclonal Antibody market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Arginase 1 Monoclonal Antibody and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Arginase 1 Monoclonal Antibody sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Arginase 1 Monoclonal Antibody market size, projected growth trends, production technologies, key applications, and end-use industries.

Arginase 1 Monoclonal Antibody Segment by Company

Sino Biological, Inc.

ZodelBiotec Ltd.

MyBiosource, Inc.

Innovative Research

Geno Technology, Inc.

CUSABIO

Creative Diagnostics

CLOUD-CLONE CORP.

Biomatik

Assay Genie

Abbexa

Arginase 1 Monoclonal Antibody Segment by Type

Recombinant

Non-recombinant

Arginase 1 Monoclonal Antibody Segment by Application

Immunofluorescence

Immunoprecipitation

ELISA

Flow Cytometry

Western Blot

Other

Arginase 1 Monoclonal Antibody Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Arginase 1 Monoclonal Antibody status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Arginase 1 Monoclonal Antibody market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Arginase 1 Monoclonal Antibody significant trends, drivers, influence factors in global and regions.

6. To analyze Arginase 1 Monoclonal Antibody competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Arginase 1 Monoclonal Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Arginase 1 Monoclonal Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Arginase 1 Monoclonal Antibody.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Arginase 1 Monoclonal Antibody market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Arginase 1 Monoclonal Antibody industry.

Chapter 3: Detailed analysis of Arginase 1 Monoclonal Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Arginase 1 Monoclonal Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Arginase 1 Monoclonal Antibody in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Arginase 1 Monoclonal Antibody Industry Trends Table 2. Arginase 1 Monoclonal Antibody Industry Drivers Table 3. Arginase 1 Monoclonal Antibody Industry Opportunities and Challenges Table 4. Arginase 1 Monoclonal Antibody Industry Restraints Table 5. Global Arginase 1 Monoclonal Antibody Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Arginase 1 Monoclonal Antibody Revenue Share by Company (2021-2026) Table 7. Global Arginase 1 Monoclonal Antibody Sales Volume by Company (k units) & (2021-2026) Table 8. Global Arginase 1 Monoclonal Antibody Sales Volume Share by Company (2021-2026) Table 9. Global Arginase 1 Monoclonal Antibody Average Price (US$/unit) of Company (2021-2026) Table 10. Global Arginase 1 Monoclonal Antibody Company Ranking, (2024-2026) & (USD Million) Table 11. Global Arginase 1 Monoclonal Antibody Key Company Manufacturing Base & Headquarters Table 12. Global Arginase 1 Monoclonal Antibody Company, Product Type & Application Table 13. Global Arginase 1 Monoclonal Antibody Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Arginase 1 Monoclonal Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Recombinant Table 18. Significant Companies of Non-recombinant Table 19. Global Arginase 1 Monoclonal Antibody Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Arginase 1 Monoclonal Antibody Sales Volume by Type (2021-2026) & (k units) Table 21. Global Arginase 1 Monoclonal Antibody Sales Volume by Type (2027-2032) & (k units) Table 22. Global Arginase 1 Monoclonal Antibody Sales Volume Share by Type (2021-2026) Table 23. Global Arginase 1 Monoclonal Antibody Sales Volume Share by Type (2027-2032) Table 24. Global Arginase 1 Monoclonal Antibody Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Arginase 1 Monoclonal Antibody Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Arginase 1 Monoclonal Antibody Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Arginase 1 Monoclonal Antibody Sales Value Share by Type (2021-2026) Table 28. Global Arginase 1 Monoclonal Antibody Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Immunofluorescence Table 30. Significant Companies of Immunoprecipitation Table 31. Significant Companies of ELISA Table 32. Significant Companies of Flow Cytometry Table 33. Significant Companies of Western Blot Table 34. Significant Companies of Other Table 35. Global Arginase 1 Monoclonal Antibody Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Arginase 1 Monoclonal Antibody Sales Volume by Application (2021-2026) & (k units) Table 37. Global Arginase 1 Monoclonal Antibody Sales Volume by Application (2027-2032) & (k units) Table 38. Global Arginase 1 Monoclonal Antibody Sales Volume Share by Application (2021-2026) Table 39. Global Arginase 1 Monoclonal Antibody Sales Volume Share by Application (2027-2032) Table 40. Global Arginase 1 Monoclonal Antibody Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Arginase 1 Monoclonal Antibody Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Arginase 1 Monoclonal Antibody Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Arginase 1 Monoclonal Antibody Sales Value Share by Application (2021-2026) Table 44. Global Arginase 1 Monoclonal Antibody Sales Value Share by Application (2027-2032) Table 45. Global Arginase 1 Monoclonal Antibody Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Arginase 1 Monoclonal Antibody Sales by Region (2021-2026) & (k units) Table 47. Global Arginase 1 Monoclonal Antibody Sales Market Share by Region (2021-2026) Table 48. Global Arginase 1 Monoclonal Antibody Sales by Region (2027-2032) & (k units) Table 49. Global Arginase 1 Monoclonal Antibody Sales Market Share by Region (2027-2032) Table 50. Global Arginase 1 Monoclonal Antibody Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Arginase 1 Monoclonal Antibody Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Arginase 1 Monoclonal Antibody Sales Value Share by Region (2021-2026) Table 53. Global Arginase 1 Monoclonal Antibody Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Arginase 1 Monoclonal Antibody Sales Value Share by Region (2027-2032) Table 55. Global Arginase 1 Monoclonal Antibody Market Average Price (US$/unit) by Region (2021-2026) Table 56. Global Arginase 1 Monoclonal Antibody Market Average Price (US$/unit) by Region (2027-2032) Table 57. Global Arginase 1 Monoclonal Antibody Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 58. Global Arginase 1 Monoclonal Antibody Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Arginase 1 Monoclonal Antibody Sales by Country (2021-2026) & (k units) Table 60. Global Arginase 1 Monoclonal Antibody Sales Market Share by Country (2021-2026) Table 61. Global Arginase 1 Monoclonal Antibody Sales by Country (2027-2032) & (k units) Table 62. Global Arginase 1 Monoclonal Antibody Sales Market Share by Country (2027-2032) Table 63. Global Arginase 1 Monoclonal Antibody Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Arginase 1 Monoclonal Antibody Sales Value Market Share by Country (2021-2026) Table 65. Global Arginase 1 Monoclonal Antibody Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Arginase 1 Monoclonal Antibody Sales Value Market Share by Country (2027-2032) Table 67. Sino Biological, Inc. Company Information Table 68. Sino Biological, Inc. Business Overview Table 69. Sino Biological, Inc. Arginase 1 Monoclonal Antibody Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Sino Biological, Inc. Arginase 1 Monoclonal Antibody Product Portfolio Table 71. Sino Biological, Inc. Recent Development Table 72. ZodelBiotec Ltd. Company Information Table 73. ZodelBiotec Ltd. Business Overview Table 74. ZodelBiotec Ltd. Arginase 1 Monoclonal Antibody Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. ZodelBiotec Ltd. Arginase 1 Monoclonal Antibody Product Portfolio Table 76. ZodelBiotec Ltd. Recent Development Table 77. MyBiosource, Inc. Company Information Table 78. MyBiosource, Inc. Business Overview Table 79. MyBiosource, Inc. Arginase 1 Monoclonal Antibody Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. MyBiosource, Inc. Arginase 1 Monoclonal Antibody Product Portfolio Table 81. MyBiosource, Inc. Recent Development Table 82. Innovative Research Company Information Table 83. Innovative Research Business Overview Table 84. Innovative Research Arginase 1 Monoclonal Antibody Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Innovative Research Arginase 1 Monoclonal Antibody Product Portfolio Table 86. Innovative Research Recent Development Table 87. Geno Technology, Inc. Company Information Table 88. Geno Technology, Inc. Business Overview Table 89. Geno Technology, Inc. Arginase 1 Monoclonal Antibody Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Geno Technology, Inc. Arginase 1 Monoclonal Antibody Product Portfolio Table 91. Geno Technology, Inc. Recent Development Table 92. CUSABIO Company Information Table 93. CUSABIO Business Overview Table 94. CUSABIO Arginase 1 Monoclonal Antibody Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. CUSABIO Arginase 1 Monoclonal Antibody Product Portfolio Table 96. CUSABIO Recent Development Table 97. Creative Diagnostics Company Information Table 98. Creative Diagnostics Business Overview Table 99. Creative Diagnostics Arginase 1 Monoclonal Antibody Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Creative Diagnostics Arginase 1 Monoclonal Antibody Product Portfolio Table 101. Creative Diagnostics Recent Development Table 102. CLOUD-CLONE CORP. Company Information Table 103. CLOUD-CLONE CORP. Business Overview Table 104. CLOUD-CLONE CORP. Arginase 1 Monoclonal Antibody Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. CLOUD-CLONE CORP. Arginase 1 Monoclonal Antibody Product Portfolio Table 106. CLOUD-CLONE CORP. Recent Development Table 107. Biomatik Company Information Table 108. Biomatik Business Overview Table 109. Biomatik Arginase 1 Monoclonal Antibody Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Biomatik Arginase 1 Monoclonal Antibody Product Portfolio Table 111. Biomatik Recent Development Table 112. Assay Genie Company Information Table 113. Assay Genie Business Overview Table 114. Assay Genie Arginase 1 Monoclonal Antibody Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. Assay Genie Arginase 1 Monoclonal Antibody Product Portfolio Table 116. Assay Genie Recent Development Table 117. Abbexa Company Information Table 118. Abbexa Business Overview Table 119. Abbexa Arginase 1 Monoclonal Antibody Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. Abbexa Arginase 1 Monoclonal Antibody Product Portfolio Table 121. Abbexa Recent Development Table 122. Key Raw Materials Table 123. Raw Materials Key Suppliers Table 124. Arginase 1 Monoclonal Antibody Distributors List Table 125. Arginase 1 Monoclonal Antibody Customers List Table 126. Research Programs/Design for This Report Table 127. Authors List of This Report Table 128. Secondary Sources Table 129. Primary Sources List of Figures Figure 1. Arginase 1 Monoclonal Antibody Product Image Figure 2. Global Arginase 1 Monoclonal Antibody Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Arginase 1 Monoclonal Antibody Sales Value (2021-2032) & (US$ Million) Figure 4. Global Arginase 1 Monoclonal Antibody Sales (2021-2032) & (k units) Figure 5. Global Arginase 1 Monoclonal Antibody Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Arginase 1 Monoclonal Antibody Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Recombinant Image Figure 10. Non-recombinant Image Figure 11. Global Arginase 1 Monoclonal Antibody Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Arginase 1 Monoclonal Antibody Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Arginase 1 Monoclonal Antibody Sales Volume Share by Type (2021-2032) Figure 14. Global Arginase 1 Monoclonal Antibody Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Arginase 1 Monoclonal Antibody Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Arginase 1 Monoclonal Antibody Sales Value Share by Type (2021-2032) Figure 17. Immunofluorescence Image Figure 18. Immunoprecipitation Image Figure 19. ELISA Image Figure 20. Flow Cytometry Image Figure 21. Western Blot Image Figure 22. Other Image Figure 23. Global Arginase 1 Monoclonal Antibody Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Arginase 1 Monoclonal Antibody Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Arginase 1 Monoclonal Antibody Sales Volume Share by Application (2021-2032) Figure 26. Global Arginase 1 Monoclonal Antibody Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Arginase 1 Monoclonal Antibody Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Arginase 1 Monoclonal Antibody Sales Value Share by Application (2021-2032) Figure 29. Global Arginase 1 Monoclonal Antibody Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 30. Global Arginase 1 Monoclonal Antibody Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Arginase 1 Monoclonal Antibody Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Arginase 1 Monoclonal Antibody Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Arginase 1 Monoclonal Antibody Sales Value (2021-2032) & (US$ Million) Figure 34. North America Arginase 1 Monoclonal Antibody Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Arginase 1 Monoclonal Antibody Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Arginase 1 Monoclonal Antibody Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Arginase 1 Monoclonal Antibody Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Arginase 1 Monoclonal Antibody Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Arginase 1 Monoclonal Antibody Sales Value (2021-2032) & (US$ Million) Figure 40. South America Arginase 1 Monoclonal Antibody Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Arginase 1 Monoclonal Antibody Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Arginase 1 Monoclonal Antibody Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Arginase 1 Monoclonal Antibody Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Arginase 1 Monoclonal Antibody Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Recombinant
  • Non-recombinant
Applications
  • Immunofluorescence
  • Immunoprecipitation
  • ELISA
  • Flow Cytometry
  • Western Blot
  • Other
Companies covered
  • Sino Biological, Inc.
  • ZodelBiotec Ltd.
  • MyBiosource, Inc.
  • Innovative Research
  • Geno Technology, Inc.
  • CUSABIO
  • Creative Diagnostics
  • CLOUD-CLONE CORP.
  • Biomatik
  • Assay Genie
  • Abbexa

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Arginase 1 Monoclonal Antibody Sales Value (2021-2032)
  4. 1.2.2 Global Arginase 1 Monoclonal Antibody Sales Volume (2021-2032)
  5. 1.2.3 Global Arginase 1 Monoclonal Antibody Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Arginase 1 Monoclonal Antibody Market Dynamics
  1. 2.1 Arginase 1 Monoclonal Antibody Industry Trends
  2. 2.2 Arginase 1 Monoclonal Antibody Industry Drivers
  3. 2.3 Arginase 1 Monoclonal Antibody Industry Opportunities and Challenges
  4. 2.4 Arginase 1 Monoclonal Antibody Industry Restraints
3 Arginase 1 Monoclonal Antibody Market by Company
  1. 3.1 Global Arginase 1 Monoclonal Antibody Company Revenue Ranking in 2025
  2. 3.2 Global Arginase 1 Monoclonal Antibody Revenue by Company (2021-2026)
  3. 3.3 Global Arginase 1 Monoclonal Antibody Sales Volume by Company (2021-2026)
  4. 3.4 Global Arginase 1 Monoclonal Antibody Average Price by Company (2021-2026)
  5. 3.5 Global Arginase 1 Monoclonal Antibody Company Ranking (2024-2026)
  6. 3.6 Global Arginase 1 Monoclonal Antibody Company Manufacturing Base and Headquarters
  7. 3.7 Global Arginase 1 Monoclonal Antibody Company Product Type and Application
  8. 3.8 Global Arginase 1 Monoclonal Antibody Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Arginase 1 Monoclonal Antibody Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Arginase 1 Monoclonal Antibody Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Arginase 1 Monoclonal Antibody Market by Type
  1. 4.1 Arginase 1 Monoclonal Antibody Type Introduction
  2. 4.1.1 Recombinant
  3. 4.1.2 Non-recombinant
  4. 4.2 Global Arginase 1 Monoclonal Antibody Sales Volume by Type
  5. 4.2.1 Global Arginase 1 Monoclonal Antibody Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Arginase 1 Monoclonal Antibody Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Arginase 1 Monoclonal Antibody Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Arginase 1 Monoclonal Antibody Sales Value by Type
  9. 4.3.1 Global Arginase 1 Monoclonal Antibody Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Arginase 1 Monoclonal Antibody Sales Value by Type (2021-2032)
  11. 4.3.3 Global Arginase 1 Monoclonal Antibody Sales Value Share by Type (2021-2032)
5 Arginase 1 Monoclonal Antibody Market by Application
  1. 5.1 Arginase 1 Monoclonal Antibody Application Introduction
  2. 5.1.1 Immunofluorescence
  3. 5.1.2 Immunoprecipitation
  4. 5.1.3 ELISA
  5. 5.1.4 Flow Cytometry
  6. 5.1.5 Western Blot
  7. 5.1.6 Other
  8. 5.2 Global Arginase 1 Monoclonal Antibody Sales Volume by Application
  9. 5.2.1 Global Arginase 1 Monoclonal Antibody Sales Volume by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Arginase 1 Monoclonal Antibody Sales Volume by Application (2021-2032)
  11. 5.2.3 Global Arginase 1 Monoclonal Antibody Sales Volume Share by Application (2021-2032)
  12. 5.3 Global Arginase 1 Monoclonal Antibody Sales Value by Application
  13. 5.3.1 Global Arginase 1 Monoclonal Antibody Sales Value by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global Arginase 1 Monoclonal Antibody Sales Value by Application (2021-2032)
  15. 5.3.3 Global Arginase 1 Monoclonal Antibody Sales Value Share by Application (2021-2032)
6 Arginase 1 Monoclonal Antibody Regional Sales and Value Analysis
  1. 6.1 Global Arginase 1 Monoclonal Antibody Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Arginase 1 Monoclonal Antibody Sales by Region (2021-2032)
  3. 6.2.1 Global Arginase 1 Monoclonal Antibody Sales by Region: 2021-2026
  4. 6.2.2 Global Arginase 1 Monoclonal Antibody Sales by Region (2027-2032)
  5. 6.3 Global Arginase 1 Monoclonal Antibody Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Arginase 1 Monoclonal Antibody Sales Value by Region (2021-2032)
  7. 6.4.1 Global Arginase 1 Monoclonal Antibody Sales Value by Region: 2021-2026
  8. 6.4.2 Global Arginase 1 Monoclonal Antibody Sales Value by Region (2027-2032)
  9. 6.5 Global Arginase 1 Monoclonal Antibody Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Arginase 1 Monoclonal Antibody Sales Value (2021-2032)
  12. 6.6.2 North America Arginase 1 Monoclonal Antibody Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Arginase 1 Monoclonal Antibody Sales Value (2021-2032)
  15. 6.7.2 Europe Arginase 1 Monoclonal Antibody Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Arginase 1 Monoclonal Antibody Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Arginase 1 Monoclonal Antibody Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Arginase 1 Monoclonal Antibody Sales Value (2021-2032)
  21. 6.9.2 South America Arginase 1 Monoclonal Antibody Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Arginase 1 Monoclonal Antibody Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Arginase 1 Monoclonal Antibody Sales Value Share by Country, 2025 VS 2032
7 Arginase 1 Monoclonal Antibody Country-level Sales and Value Analysis
  1. 7.1 Global Arginase 1 Monoclonal Antibody Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Arginase 1 Monoclonal Antibody Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Arginase 1 Monoclonal Antibody Sales by Country (2021-2032)
  4. 7.3.1 Global Arginase 1 Monoclonal Antibody Sales by Country (2021-2026)
  5. 7.3.2 Global Arginase 1 Monoclonal Antibody Sales by Country (2027-2032)
  6. 7.4 Global Arginase 1 Monoclonal Antibody Sales Value by Country (2021-2032)
  7. 7.4.1 Global Arginase 1 Monoclonal Antibody Sales Value by Country (2021-2026)
  8. 7.4.2 Global Arginase 1 Monoclonal Antibody Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Arginase 1 Monoclonal Antibody Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Arginase 1 Monoclonal Antibody Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Arginase 1 Monoclonal Antibody Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sino Biological, Inc.
  2. 8.1.1 Sino Biological, Inc. Company Information
  3. 8.1.2 Sino Biological, Inc. Business Overview
  4. 8.1.3 Sino Biological, Inc. Arginase 1 Monoclonal Antibody Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sino Biological, Inc. Arginase 1 Monoclonal Antibody Product Portfolio
  6. 8.1.5 Sino Biological, Inc. Recent Developments
  7. 8.2 ZodelBiotec Ltd.
  8. 8.2.1 ZodelBiotec Ltd. Company Information
  9. 8.2.2 ZodelBiotec Ltd. Business Overview
  10. 8.2.3 ZodelBiotec Ltd. Arginase 1 Monoclonal Antibody Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 ZodelBiotec Ltd. Arginase 1 Monoclonal Antibody Product Portfolio
  12. 8.2.5 ZodelBiotec Ltd. Recent Developments
  13. 8.3 MyBiosource, Inc.
  14. 8.3.1 MyBiosource, Inc. Company Information
  15. 8.3.2 MyBiosource, Inc. Business Overview
  16. 8.3.3 MyBiosource, Inc. Arginase 1 Monoclonal Antibody Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 MyBiosource, Inc. Arginase 1 Monoclonal Antibody Product Portfolio
  18. 8.3.5 MyBiosource, Inc. Recent Developments
  19. 8.4 Innovative Research
  20. 8.4.1 Innovative Research Company Information
  21. 8.4.2 Innovative Research Business Overview
  22. 8.4.3 Innovative Research Arginase 1 Monoclonal Antibody Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Innovative Research Arginase 1 Monoclonal Antibody Product Portfolio
  24. 8.4.5 Innovative Research Recent Developments
  25. 8.5 Geno Technology, Inc.
  26. 8.5.1 Geno Technology, Inc. Company Information
  27. 8.5.2 Geno Technology, Inc. Business Overview
  28. 8.5.3 Geno Technology, Inc. Arginase 1 Monoclonal Antibody Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Geno Technology, Inc. Arginase 1 Monoclonal Antibody Product Portfolio
  30. 8.5.5 Geno Technology, Inc. Recent Developments
  31. 8.6 CUSABIO
  32. 8.6.1 CUSABIO Company Information
  33. 8.6.2 CUSABIO Business Overview
  34. 8.6.3 CUSABIO Arginase 1 Monoclonal Antibody Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 CUSABIO Arginase 1 Monoclonal Antibody Product Portfolio
  36. 8.6.5 CUSABIO Recent Developments
  37. 8.7 Creative Diagnostics
  38. 8.7.1 Creative Diagnostics Company Information
  39. 8.7.2 Creative Diagnostics Business Overview
  40. 8.7.3 Creative Diagnostics Arginase 1 Monoclonal Antibody Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Creative Diagnostics Arginase 1 Monoclonal Antibody Product Portfolio
  42. 8.7.5 Creative Diagnostics Recent Developments
  43. 8.8 CLOUD-CLONE CORP.
  44. 8.8.1 CLOUD-CLONE CORP. Company Information
  45. 8.8.2 CLOUD-CLONE CORP. Business Overview
  46. 8.8.3 CLOUD-CLONE CORP. Arginase 1 Monoclonal Antibody Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 CLOUD-CLONE CORP. Arginase 1 Monoclonal Antibody Product Portfolio
  48. 8.8.5 CLOUD-CLONE CORP. Recent Developments
  49. 8.9 Biomatik
  50. 8.9.1 Biomatik Company Information
  51. 8.9.2 Biomatik Business Overview
  52. 8.9.3 Biomatik Arginase 1 Monoclonal Antibody Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Biomatik Arginase 1 Monoclonal Antibody Product Portfolio
  54. 8.9.5 Biomatik Recent Developments
  55. 8.10 Assay Genie
  56. 8.10.1 Assay Genie Company Information
  57. 8.10.2 Assay Genie Business Overview
  58. 8.10.3 Assay Genie Arginase 1 Monoclonal Antibody Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Assay Genie Arginase 1 Monoclonal Antibody Product Portfolio
  60. 8.10.5 Assay Genie Recent Developments
  61. 8.11 Abbexa
  62. 8.11.1 Abbexa Company Information
  63. 8.11.2 Abbexa Business Overview
  64. 8.11.3 Abbexa Arginase 1 Monoclonal Antibody Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Abbexa Arginase 1 Monoclonal Antibody Product Portfolio
  66. 8.11.5 Abbexa Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Arginase 1 Monoclonal Antibody Value Chain Analysis
  2. 9.1.1 Arginase 1 Monoclonal Antibody Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Arginase 1 Monoclonal Antibody Sales Mode & Process
  6. 9.2 Arginase 1 Monoclonal Antibody Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Arginase 1 Monoclonal Antibody Distributors
  9. 9.2.3 Arginase 1 Monoclonal Antibody Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst